Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG) [Phase 2]

View source ↗

Summary

A Phase 2 study by Amgen is evaluating the pharmacokinetics, pharmacodynamics, safety, and tolerability of Inebilizumab in children with Generalized Myasthenia …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Myasthenia Gravis

Drugs mentioned

• Inebilizumab (inebilizumab)

Snippet

Sponsor: Amgen | Conditions: Generalized Myasthenia Gravis | Phase 2 | Status: RECRUITING